what is glp-1 agonist therapy glp-1_analogs [TUSOM GLP-1 Agonists For Obesity In

Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)

Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.

Originally designed to manage type 2 diabetes (T2D), these drugs have rapidly expanded their therapeutic reach, offering significant benefits for ob

Compare 10 GLP-1 agonist medications for weight loss including semaglutide and tirzepatide

From weight loss breakthroughsto type 2 diabetes management, and even anti-aging medicine, these treatments offer extraordinary promise.But with innovation comes risk

De Giorgi and colleagues present a comprehensive analysis of pre-clinical and clinical studies examining the role of glucagon-like peptide-1 receptor agonists in mental disorders.